Literature DB >> 16769301

Impact of obsessive-compulsive disorder on quality of life.

Jane L Eisen1, Maria A Mancebo, Anthony Pinto, Meredith E Coles, Maria E Pagano, Robert Stout, Steven A Rasmussen.   

Abstract

BACKGROUND: Although obsessive-compulsive disorder (OCD) has been found to be the 10th leading cause of disability of all medical conditions in the industrialized world, comparatively little is known about psychosocial functioning and quality of life (QOL) in OCD, particularly with regard to their relationship with symptom severity.
METHOD: Quality of life and psychosocial function of 197 adults were assessed as part of a larger intake interview for a 5-year prospective study of OCD course. Two self-report measures (the Quality of Life Enjoyment and the Medical Outcomes Survey 36-Item Short-Form Health Survey) and 2 clinician-rated measures (the Range of Impaired Functioning Tool and the Social and Occupational Functioning Assessment Scale), each with established reliability and validity, were administered. Symptom severity was assessed with the Yale-Brown Obsessive-Compulsive Scale (YBOCS).
RESULTS: Quality of life was significantly impaired compared with published community norms with large effect sizes found for all domains assessed. The correlations (r) between all QOL measures and the YBOCS total score were significant, ranging from 0.40 to 0.77. Correlations between the YBOCS obsessions subscore and QOL measures were higher than those found between the YBOCS compulsions subscore and QOL. Insight as measured by the Brown Assessment of Beliefs Scale was significantly correlated with 5 of the 7 measures, although more modestly than the YBOCS correlations (r = 0.22 to 0.37). Subjects with a YBOCS score of 20 or higher had significant decline in QOL compared with those subjects with YBOCS scores lower than 20. Severity of obsessions and depressive symptoms, as well as marital status, were significant predictors of impairment in QOL.
CONCLUSIONS: These findings indicate that all aspects of QOL are markedly affected in individuals with OCD and are associated with OCD severity (particularly obsessional severity) and depression severity. Exploratory results suggest that QOL and psychosocial functioning begins to be more significantly affected at YBOCS scores higher than 20. This score might be considered as a threshold criterion for OCD for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

Entities:  

Mesh:

Year:  2006        PMID: 16769301      PMCID: PMC2633465          DOI: 10.1016/j.comppsych.2005.11.006

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  15 in total

1.  Social functioning and quality of life comparisons between obsessive-compulsive and schizophrenic disorders.

Authors:  A Bystritsky; R P Liberman; S Hwang; C J Wallace; T Vapnik; K Maindment; S Saxena
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

2.  Obsessive-compulsive and spectrum disorders: overview and quality of life issues.

Authors:  E Hollander; J H Kwon; D J Stein; J Broatch; C T Rowland; C A Himelein
Journal:  J Clin Psychiatry       Date:  1996       Impact factor: 4.384

3.  Quality of life and pharmaco-economic aspects of obsessive-compulsive disorder. A South African survey.

Authors:  D J Stein; M Roberts; E Hollander; C Rowland; P Serebro
Journal:  S Afr Med J       Date:  1996-12

4.  Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program.

Authors:  A Bystritsky; S Saxena; K Maidment; T Vapnik; G Tarlow; R Rosen
Journal:  Psychiatr Serv       Date:  1999-03       Impact factor: 3.084

5.  The Brown Assessment of Beliefs Scale: reliability and validity.

Authors:  J L Eisen; K A Phillips; L Baer; D A Beer; K D Atala; S A Rasmussen
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

6.  The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment.

Authors:  A C Leon; D A Solomon; T I Mueller; C L Turvey; J Endicott; M B Keller
Journal:  Psychol Med       Date:  1999-07       Impact factor: 7.723

7.  Quality of life with OCD. A self-reported survey among members of the Danish OCD Association.

Authors:  Christine B Sørensen; Line Kirkeby; Per Hove Thomsen
Journal:  Nord J Psychiatry       Date:  2004       Impact factor: 2.202

8.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

9.  Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.

Authors:  Nienke H Tenney; Damiaan A J P Denys; Harold J G M van Megen; Gerrit Glas; Herman G M Westenberg
Journal:  Int Clin Psychopharmacol       Date:  2003-01       Impact factor: 1.659

10.  The Modified Hamilton Rating Scale for Depression: reliability and validity.

Authors:  I W Miller; S Bishop; W H Norman; H Maddever
Journal:  Psychiatry Res       Date:  1985-02       Impact factor: 3.222

View more
  72 in total

Review 1.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

2.  Predicting course of illness in patients with severe obsessive-compulsive disorder.

Authors:  Sarah L Garnaat; Christina L Boisseau; Agustin Yip; Nicholas J Sibrava; Benjamin D Greenberg; Maria C Mancebo; Nicole C R McLaughlin; Jane L Eisen; Steven A Rasmussen
Journal:  J Clin Psychiatry       Date:  2015-12       Impact factor: 4.384

3.  Symptom subtype and quality of life in obsessive-compulsive disorder.

Authors:  Carly M Schwartzman; Christina L Boisseau; Nicholas J Sibrava; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen
Journal:  Psychiatry Res       Date:  2017-01-20       Impact factor: 3.222

4.  Assessment of Quality of Life (QOL) in Obsessive Compulsive Disorder (OCD) and Dysthymic Disorder (DD): A Comparative Study.

Authors:  Roopesh Gopal Nariyandada Vasudev; Sudarshan Chikkanayakanahalli Yallappa; Ganesh Kumar Saya
Journal:  J Clin Diagn Res       Date:  2015-05-01

5.  Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods.

Authors:  Christina L Boisseau; Steven A Rasmussen
Journal:  Contemp Clin Trials       Date:  2018-01-03       Impact factor: 2.226

6.  IMPROVEMENTS IN PSYCHOSOCIAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE FOLLOWING EXERCISE AUGMENTATION IN PATIENTS WITH TREATMENT RESPONSE BUT NONREMITTED MAJOR DEPRESSIVE DISORDER: RESULTS FROM THE TREAD STUDY.

Authors:  Tracy L Greer; Joseph M Trombello; Chad D Rethorst; Thomas J Carmody; Manish K Jha; Allen Liao; Bruce D Grannemann; Heather O Chambliss; Timothy S Church; Madhukar H Trivedi
Journal:  Depress Anxiety       Date:  2016-05-10       Impact factor: 6.505

7.  Quality of life and functional impairment in obsessive-compulsive disorder: a comparison of patients with and without comorbidity, patients in remission, and healthy controls.

Authors:  Jonathan D Huppert; H Blair Simpson; Kore J Nissenson; Michael R Liebowitz; Edna B Foa
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

8.  Obsessive-compulsive disorder: Evidence-based treatments and future directions for research.

Authors:  Caleb W Lack
Journal:  World J Psychiatry       Date:  2012-12-22

9.  Demographic and health-related correlates of obsessive-compulsive symptoms among African Americans.

Authors:  Monnica T Williams; Robert Joseph Taylor; Joseph A Himle; Linda M Chatters
Journal:  J Obsessive Compuls Relat Disord       Date:  2017-07-08       Impact factor: 1.677

Review 10.  Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment.

Authors:  Mythily Subramaniam; Pauline Soh; Janhavi Ajit Vaingankar; Louisa Picco; Siow Ann Chong
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.